Federal Register Announcement of meeting: “Regulatory New Drug Review: Solutions for Study Data Exchange Standards” to be held 11/5 from 10 a.m. to 4 p.m. at the FDA White Oak Campus, 10903 New Hampshire Ave., Building 31 Conference Center, the Great Room (Rm. 1503), Silver Spring, MD. FDA plans to solicit input from industry, technology vendors, and other members of the public on the advantages and disadvantages of current and emerging open, consensus-based standards for the exchange of regulated study data. FDA also seeks input from stakeholders and other members of the public on this topic and a set of premeeting questions. Contact Ron Fitzmartin, (301) 796-5333. To view this announcement, click here.